Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
AIMS Microbiology is Scopus-indexed (Q1, CiteScore 7.6), WoS ESCI. Published by AIMS Press.
Checked against the index lists dated .
ISSN 2471-1888Verify ISSN ↗
Publisher: AIMS Press
Cost to publish: About US$300 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Microbiology (medical) | 33 / 147 | 77th | Q1 |
| Microbiology | 46 / 194 | 76th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 7.6.
AIMS Microbiology is Q1 in Microbiology (medical) (rank 33 of 147) and Q1 in Microbiology (rank 46 of 194), by CiteScore 2025.
AIMS Microbiology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.6, which places it in quartile Q1 at the 77th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.067, quartile Q1, with an H-index of 34.
The publisher lists an article processing charge of about US$300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
AIMS Microbiology is published by AIMS Press. Its ISSN is 2471-1888.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
AIMS Microbiology has an h-index of 44 and a 2-year mean of 7.19 citations per paper (OpenAlex). Its Scopus CiteScore is 7.6, quartile Q1. On 2-year citations it ranks #13 of 144 Scopus journals in Microbiology (medical).
AIMS Microbiology published 45 papers in 2025; its busiest recent year was 2017 with 58. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from China (15.3%), Italy (10.8%) and United States (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.